Back

Treatment quality in patients with familial hypercholesterolemia in Denmark

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Lipids (1) Lipids ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jakob Knold

Odense University Hospital, Odense (Denmark)

4 More presentations in this session

Presentation thumbnail
Predictive value of blood count derived inflammatory markers for LDL cholesterol target achievement after STEMI
Doctor V. Halatiu (Targu Mures, RO)
Abstract Slides Video
Presentation thumbnail
Suboptimal LDL-C control despite high statin use: insights from the LAI-LCARE survey on secondary CAD prevention in India
Doctor K. Mahajan (Himachal Pradesh, IN)
Abstract Slides Video
Presentation thumbnail
The SLCO1B1 c.521 T > C variant is not associated with muscular symptoms or PCSK9-inhibitor prescription in patients with severe hypercholesterolemia
Doctor L. Galli (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Early post-discharge follow-up improves lipid control and reduces cardiovascular risk in ACS patients: insights from a tertiary cardiac centre
Doctor A. Elkammash (Bristol, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Validation of the familial hypercholesterolemia diagnosis in the Danish National Patient Registry and the Danish familial hypercholesterolemia registry
thumbnail
Congress Presentation
Cardiovascular risk among individuals with and without genetic mutation for familial hypercholesterolemia: A long-term follow-up study
thumbnail
Congress Presentation
Comparing achieved treatment targets of genetically confirmed familial hypercholesterolaemia patients followed by primary versus secondary care. a real-world experience from a tertiary welsh centre.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources